Overview
Sheldon Holder is a Hematologist Oncology specialist and a Hematologist in Grand Rapids, Michigan. Dr. Holder is rated as an Advanced provider by MediFind in the treatment of Wilms Tumor. His top areas of expertise are Bladder Cancer, Renal Cell Carcinoma (RCC), Urothelial Cancer, Chromophobe Renal Cell Carcinoma, and Tissue Biopsy.
His clinical research consists of co-authoring 26 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- MANAGED MEDICAID PLAN
- MEDICARE ASSISTANCE PROGRAM
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- HMO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
250 Cherry St Se, Grand Rapids, MI 49503
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Advantage Health/saint Mary's Medical Group
Peter Van Veldhuizen is a Hematologist Oncology specialist and a Hematologist in Grand Rapids, Michigan. Dr. Van Veldhuizen is rated as an Advanced provider by MediFind in the treatment of Wilms Tumor. His top areas of expertise are WT1-Related Wilms Tumor Syndromes, Clear Cell Sarcoma, Renal Cell Carcinoma (RCC), and Chromophobe Renal Cell Carcinoma. Dr. Van Veldhuizen is currently accepting new patients.
Corewell Health Medical Oncology Program - Lemmen-Holton
Emerson Lim is a Hematologist Oncology specialist and an Oncologist in Grand Rapids, Michigan. Dr. Lim has been practicing medicine for over 20 years and is rated as a Distinguished provider by MediFind in the treatment of Wilms Tumor. His top areas of expertise are Prostate Cancer, Clear Cell Sarcoma, WT1-Related Wilms Tumor Syndromes, and Chromophobe Renal Cell Carcinoma.
Newaygo County General Hospital Association
Salah Almokadem is a Hematologist Oncology specialist and a Hematologist in Fremont, Michigan. Dr. Almokadem is rated as a Distinguished provider by MediFind in the treatment of Wilms Tumor. His top areas of expertise are Pleuropulmonary Blastoma, Small Cell Lung Cancer (SCLC), ALK-Positive Non-Small Cell Lung Cancer, and Lung Adenocarcinoma.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Bladder CancerDr. Holder isDistinguished. Learn about Bladder Cancer.
- Advanced
- Adult Soft Tissue SarcomaDr. Holder isAdvanced. Learn about Adult Soft Tissue Sarcoma.
- Chromophobe Renal Cell CarcinomaDr. Holder isAdvanced. Learn about Chromophobe Renal Cell Carcinoma.
- Clear Cell SarcomaDr. Holder isAdvanced. Learn about Clear Cell Sarcoma.
- Familial Prostate CancerDr. Holder isAdvanced. Learn about Familial Prostate Cancer.
- Familial Wilms Tumor 2Dr. Holder isAdvanced. Learn about Familial Wilms Tumor 2.
- Muscle Invasive Bladder CancerDr. Holder isAdvanced. Learn about Muscle Invasive Bladder Cancer.
- Experienced
- ALK-Positive Non-Small Cell Lung CancerDr. Holder isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- AnemiaDr. Holder isExperienced. Learn about Anemia.
- ChoriocarcinomaDr. Holder isExperienced. Learn about Choriocarcinoma.
- EGFR Positive Lung CancerDr. Holder isExperienced. Learn about EGFR Positive Lung Cancer.
- Hereditary Paraganglioma-Pheochromocytoma Syndrome
- Large-Cell Lung CarcinomaDr. Holder isExperienced. Learn about Large-Cell Lung Carcinoma.